0001836379-22-000019.txt : 20221219 0001836379-22-000019.hdr.sgml : 20221219 20220927141028 ACCESSION NUMBER: 0001836379-22-000019 CONFORMED SUBMISSION TYPE: CORRESP PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20220927 FILER: COMPANY DATA: COMPANY CONFORMED NAME: VectivBio Holding AG CENTRAL INDEX KEY: 0001836379 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 000000000 STATE OF INCORPORATION: V8 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: CORRESP BUSINESS ADDRESS: STREET 1: AESCHENVORSTADT 36 CITY: BASEL STATE: V8 ZIP: 4051 BUSINESS PHONE: 41 61 551 30 30 MAIL ADDRESS: STREET 1: AESCHENVORSTADT 36 CITY: BASEL STATE: V8 ZIP: 4051 CORRESP 1 filename1.htm Document

September 27, 2022

Via EDGAR

U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549

Attn:    Jane Park


Re:    VectivBio Holding AG
    Acceleration Request for Registration Statement on Form F-3
    File No. 333-265546

    
Ladies and Gentlemen:

The undersigned registrant hereby respectfully advises the staff (the “Staff”) of the U.S. Securities and Exchange Commission that it is withdrawing its previous request that the above-referenced Registration Statement be declared effective on Monday, September 26, 2022. The registrant hereby undertakes to advise the Staff regarding any future acceleration request as soon as possible.




[Signature page follows]



Very truly yours,

VectivBio Holding AG


By: /s/ Claudia D’ Augusta         
Claudia D’Augusta
Chief Financial Officer


cc:    Scott Applebaum, VectivBio Holding AG
Brandon Fenn, Cooley LLP
    Dayne Brown, Cooley LLP
Andreas Müller, Homburger AG